Loading…

Dosimetric Comparison of Intraoperative Radiotherapy and SRS for Liver Metastases

To perform a dosimetric comparison between kilovoltage intraoperative radiotherapy (IORT) and stereotactic radiosurgery (SRS) simulating both deep-inspiration breath-hold (DIBH) and free-breathing (FB) modalities for patients with liver metastases. Diagnostic computed tomographies (CT) of patients c...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in oncology 2021-12, Vol.11, p.767468-767468
Main Authors: Scafa, Davide, Muedder, Thomas, Holz, Jasmin A, Koch, David, Nour, Younéss, Garbe, Stephan, Gonzalez-Carmona, Maria A, Feldmann, Georg, Vilz, Tim O, Köksal, Mümtaz, Giordano, Frank A, Schmeel, Leonard Christopher, Sarria, Gustavo R
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c415t-96dadd33dacceb2cb756863f2d0708f0f8a26eadc3df4c899315ece30203d1db3
container_end_page 767468
container_issue
container_start_page 767468
container_title Frontiers in oncology
container_volume 11
creator Scafa, Davide
Muedder, Thomas
Holz, Jasmin A
Koch, David
Nour, Younéss
Garbe, Stephan
Gonzalez-Carmona, Maria A
Feldmann, Georg
Vilz, Tim O
Köksal, Mümtaz
Giordano, Frank A
Schmeel, Leonard Christopher
Sarria, Gustavo R
description To perform a dosimetric comparison between kilovoltage intraoperative radiotherapy (IORT) and stereotactic radiosurgery (SRS) simulating both deep-inspiration breath-hold (DIBH) and free-breathing (FB) modalities for patients with liver metastases. Diagnostic computed tomographies (CT) of patients carrying one or two lesions
doi_str_mv 10.3389/fonc.2021.767468
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_54b6e3c1a79d4658a6e712651bdd8860</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_54b6e3c1a79d4658a6e712651bdd8860</doaj_id><sourcerecordid>2612021730</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-96dadd33dacceb2cb756863f2d0708f0f8a26eadc3df4c899315ece30203d1db3</originalsourceid><addsrcrecordid>eNpVkU1v1DAQhi0EolXpnRPykcsu_khs54KEFigrLUL9QOJmTexx6yqJg52t1H_fhC1Va43kGc_MM7ZfQt5ztpbSNJ9CGtxaMMHXWulKmVfkWAhZrZpK_nn9zD8ip6XcsnmpmnEm35IjWTVCCc2PyfnXVGKPU46OblI_Qo4lDTQFuh2mDGnEDFO8Q3oBPqbpZg7HewqDp5cXlzSkTHdzNtOfOEGZDcs78iZAV_D0cT8hv79_u9r8WO1-nW03X3YrV_F6WjXKg_dSenAOW-FaXSujZBCeaWYCCwaEQvBO-lA50zSS1-hQMsGk576VJ2R74PoEt3bMsYd8bxNE--8g5WsLeYquQ1tXrULpOOjGV6o2oFBzoWreem-MYjPr84E17tsevcPl7d0L6MvMEG_sdbqzZv55rpsZ8PERkNPfPZbJ9rE47DoYMO2LFYovSmm5zGKHUpdTKRnD0xjO7CKsXYS1S7k9CDu3fHh-vaeG_zLKB9wRoRM</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2612021730</pqid></control><display><type>article</type><title>Dosimetric Comparison of Intraoperative Radiotherapy and SRS for Liver Metastases</title><source>PubMed Central Free</source><creator>Scafa, Davide ; Muedder, Thomas ; Holz, Jasmin A ; Koch, David ; Nour, Younéss ; Garbe, Stephan ; Gonzalez-Carmona, Maria A ; Feldmann, Georg ; Vilz, Tim O ; Köksal, Mümtaz ; Giordano, Frank A ; Schmeel, Leonard Christopher ; Sarria, Gustavo R</creator><creatorcontrib>Scafa, Davide ; Muedder, Thomas ; Holz, Jasmin A ; Koch, David ; Nour, Younéss ; Garbe, Stephan ; Gonzalez-Carmona, Maria A ; Feldmann, Georg ; Vilz, Tim O ; Köksal, Mümtaz ; Giordano, Frank A ; Schmeel, Leonard Christopher ; Sarria, Gustavo R</creatorcontrib><description>To perform a dosimetric comparison between kilovoltage intraoperative radiotherapy (IORT) and stereotactic radiosurgery (SRS) simulating both deep-inspiration breath-hold (DIBH) and free-breathing (FB) modalities for patients with liver metastases. Diagnostic computed tomographies (CT) of patients carrying one or two lesions &lt;4 cm and who underwent surgery were retrospectively screened and randomly selected for the study. For DIBH-SRS, a gross target volume (GTV) plus planning target volume (PTV) were delineated. For FB-SRS, a GTV plus an internal target volume (ITV) and PTV were defined. Accounting for the maximal GTV diameters, a modified GTV (GTV-IORT) was expanded circumferentially to simulate a resection cavity. The best suitable round-applicator size was thereafter selected. All treatment plans were calculated homogeneously to deliver 40 Gy. Doses delivered to organs at risk (OAR) and target volumes were compared for IORT vs. both SRS modalities. Eight patients encompassing 10 lesions were included in the study. The mean liver volume was 2,050.97 cm (SD, 650.82), and the mean GTV volume was 12.23 cm (SD, 12.62). As for target structures, GTV-IORT [19.44 cm (SD, 17.26)] were significantly smaller than both PTV DIBH-SRS [30.74 cm (SD, 24.64), p = 0.002] and PTV FB-SRS [75.82 cm (SD, 45.65), p = 0.002]. The median applicator size was 3 cm (1.5-4.5), and the mean IORT simulated delivery time was 45.45 min (SD, 19.88). All constraints were met in all modalities. Liver V showed significantly smaller volumes with IORT [63.39 cm (SD, 35.67)] when compared to DIBH-SRS [150.12 cm (SD, 81.43), p = 0.002] or FB-SRS [306.13 cm (SD, 128.75), p = 0.002]. No other statistical or dosimetrically relevant difference was observed for stomach, spinal cord, or biliary tract. Mean IORT D was 85.3% (SD, 6.05), whereas D for DIBH-SRS and FB-SRS were 99.03% (SD, 1.71; p = 0.042) and 98.04% (SD, 3.46; p = 0.036), respectively. Kilovoltage IORT bears the potential as novel add-on treatment for resectable liver metastases, significantly reducing healthy liver exposure to radiation in comparison to SRS. Prospective clinical evidence is required to confirm this hypothesis.</description><identifier>ISSN: 2234-943X</identifier><identifier>EISSN: 2234-943X</identifier><identifier>DOI: 10.3389/fonc.2021.767468</identifier><identifier>PMID: 34926271</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>intraoperative ; IORT ; kilovoltage ; liver metastases ; Oncology ; SRS</subject><ispartof>Frontiers in oncology, 2021-12, Vol.11, p.767468-767468</ispartof><rights>Copyright © 2021 Scafa, Muedder, Holz, Koch, Nour, Garbe, Gonzalez-Carmona, Feldmann, Vilz, Köksal, Giordano, Schmeel and Sarria.</rights><rights>Copyright © 2021 Scafa, Muedder, Holz, Koch, Nour, Garbe, Gonzalez-Carmona, Feldmann, Vilz, Köksal, Giordano, Schmeel and Sarria 2021 Scafa, Muedder, Holz, Koch, Nour, Garbe, Gonzalez-Carmona, Feldmann, Vilz, Köksal, Giordano, Schmeel and Sarria</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c415t-96dadd33dacceb2cb756863f2d0708f0f8a26eadc3df4c899315ece30203d1db3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674179/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674179/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34926271$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Scafa, Davide</creatorcontrib><creatorcontrib>Muedder, Thomas</creatorcontrib><creatorcontrib>Holz, Jasmin A</creatorcontrib><creatorcontrib>Koch, David</creatorcontrib><creatorcontrib>Nour, Younéss</creatorcontrib><creatorcontrib>Garbe, Stephan</creatorcontrib><creatorcontrib>Gonzalez-Carmona, Maria A</creatorcontrib><creatorcontrib>Feldmann, Georg</creatorcontrib><creatorcontrib>Vilz, Tim O</creatorcontrib><creatorcontrib>Köksal, Mümtaz</creatorcontrib><creatorcontrib>Giordano, Frank A</creatorcontrib><creatorcontrib>Schmeel, Leonard Christopher</creatorcontrib><creatorcontrib>Sarria, Gustavo R</creatorcontrib><title>Dosimetric Comparison of Intraoperative Radiotherapy and SRS for Liver Metastases</title><title>Frontiers in oncology</title><addtitle>Front Oncol</addtitle><description>To perform a dosimetric comparison between kilovoltage intraoperative radiotherapy (IORT) and stereotactic radiosurgery (SRS) simulating both deep-inspiration breath-hold (DIBH) and free-breathing (FB) modalities for patients with liver metastases. Diagnostic computed tomographies (CT) of patients carrying one or two lesions &lt;4 cm and who underwent surgery were retrospectively screened and randomly selected for the study. For DIBH-SRS, a gross target volume (GTV) plus planning target volume (PTV) were delineated. For FB-SRS, a GTV plus an internal target volume (ITV) and PTV were defined. Accounting for the maximal GTV diameters, a modified GTV (GTV-IORT) was expanded circumferentially to simulate a resection cavity. The best suitable round-applicator size was thereafter selected. All treatment plans were calculated homogeneously to deliver 40 Gy. Doses delivered to organs at risk (OAR) and target volumes were compared for IORT vs. both SRS modalities. Eight patients encompassing 10 lesions were included in the study. The mean liver volume was 2,050.97 cm (SD, 650.82), and the mean GTV volume was 12.23 cm (SD, 12.62). As for target structures, GTV-IORT [19.44 cm (SD, 17.26)] were significantly smaller than both PTV DIBH-SRS [30.74 cm (SD, 24.64), p = 0.002] and PTV FB-SRS [75.82 cm (SD, 45.65), p = 0.002]. The median applicator size was 3 cm (1.5-4.5), and the mean IORT simulated delivery time was 45.45 min (SD, 19.88). All constraints were met in all modalities. Liver V showed significantly smaller volumes with IORT [63.39 cm (SD, 35.67)] when compared to DIBH-SRS [150.12 cm (SD, 81.43), p = 0.002] or FB-SRS [306.13 cm (SD, 128.75), p = 0.002]. No other statistical or dosimetrically relevant difference was observed for stomach, spinal cord, or biliary tract. Mean IORT D was 85.3% (SD, 6.05), whereas D for DIBH-SRS and FB-SRS were 99.03% (SD, 1.71; p = 0.042) and 98.04% (SD, 3.46; p = 0.036), respectively. Kilovoltage IORT bears the potential as novel add-on treatment for resectable liver metastases, significantly reducing healthy liver exposure to radiation in comparison to SRS. Prospective clinical evidence is required to confirm this hypothesis.</description><subject>intraoperative</subject><subject>IORT</subject><subject>kilovoltage</subject><subject>liver metastases</subject><subject>Oncology</subject><subject>SRS</subject><issn>2234-943X</issn><issn>2234-943X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkU1v1DAQhi0EolXpnRPykcsu_khs54KEFigrLUL9QOJmTexx6yqJg52t1H_fhC1Va43kGc_MM7ZfQt5ztpbSNJ9CGtxaMMHXWulKmVfkWAhZrZpK_nn9zD8ip6XcsnmpmnEm35IjWTVCCc2PyfnXVGKPU46OblI_Qo4lDTQFuh2mDGnEDFO8Q3oBPqbpZg7HewqDp5cXlzSkTHdzNtOfOEGZDcs78iZAV_D0cT8hv79_u9r8WO1-nW03X3YrV_F6WjXKg_dSenAOW-FaXSujZBCeaWYCCwaEQvBO-lA50zSS1-hQMsGk576VJ2R74PoEt3bMsYd8bxNE--8g5WsLeYquQ1tXrULpOOjGV6o2oFBzoWreem-MYjPr84E17tsevcPl7d0L6MvMEG_sdbqzZv55rpsZ8PERkNPfPZbJ9rE47DoYMO2LFYovSmm5zGKHUpdTKRnD0xjO7CKsXYS1S7k9CDu3fHh-vaeG_zLKB9wRoRM</recordid><startdate>20211202</startdate><enddate>20211202</enddate><creator>Scafa, Davide</creator><creator>Muedder, Thomas</creator><creator>Holz, Jasmin A</creator><creator>Koch, David</creator><creator>Nour, Younéss</creator><creator>Garbe, Stephan</creator><creator>Gonzalez-Carmona, Maria A</creator><creator>Feldmann, Georg</creator><creator>Vilz, Tim O</creator><creator>Köksal, Mümtaz</creator><creator>Giordano, Frank A</creator><creator>Schmeel, Leonard Christopher</creator><creator>Sarria, Gustavo R</creator><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20211202</creationdate><title>Dosimetric Comparison of Intraoperative Radiotherapy and SRS for Liver Metastases</title><author>Scafa, Davide ; Muedder, Thomas ; Holz, Jasmin A ; Koch, David ; Nour, Younéss ; Garbe, Stephan ; Gonzalez-Carmona, Maria A ; Feldmann, Georg ; Vilz, Tim O ; Köksal, Mümtaz ; Giordano, Frank A ; Schmeel, Leonard Christopher ; Sarria, Gustavo R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-96dadd33dacceb2cb756863f2d0708f0f8a26eadc3df4c899315ece30203d1db3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>intraoperative</topic><topic>IORT</topic><topic>kilovoltage</topic><topic>liver metastases</topic><topic>Oncology</topic><topic>SRS</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Scafa, Davide</creatorcontrib><creatorcontrib>Muedder, Thomas</creatorcontrib><creatorcontrib>Holz, Jasmin A</creatorcontrib><creatorcontrib>Koch, David</creatorcontrib><creatorcontrib>Nour, Younéss</creatorcontrib><creatorcontrib>Garbe, Stephan</creatorcontrib><creatorcontrib>Gonzalez-Carmona, Maria A</creatorcontrib><creatorcontrib>Feldmann, Georg</creatorcontrib><creatorcontrib>Vilz, Tim O</creatorcontrib><creatorcontrib>Köksal, Mümtaz</creatorcontrib><creatorcontrib>Giordano, Frank A</creatorcontrib><creatorcontrib>Schmeel, Leonard Christopher</creatorcontrib><creatorcontrib>Sarria, Gustavo R</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Scafa, Davide</au><au>Muedder, Thomas</au><au>Holz, Jasmin A</au><au>Koch, David</au><au>Nour, Younéss</au><au>Garbe, Stephan</au><au>Gonzalez-Carmona, Maria A</au><au>Feldmann, Georg</au><au>Vilz, Tim O</au><au>Köksal, Mümtaz</au><au>Giordano, Frank A</au><au>Schmeel, Leonard Christopher</au><au>Sarria, Gustavo R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dosimetric Comparison of Intraoperative Radiotherapy and SRS for Liver Metastases</atitle><jtitle>Frontiers in oncology</jtitle><addtitle>Front Oncol</addtitle><date>2021-12-02</date><risdate>2021</risdate><volume>11</volume><spage>767468</spage><epage>767468</epage><pages>767468-767468</pages><issn>2234-943X</issn><eissn>2234-943X</eissn><abstract>To perform a dosimetric comparison between kilovoltage intraoperative radiotherapy (IORT) and stereotactic radiosurgery (SRS) simulating both deep-inspiration breath-hold (DIBH) and free-breathing (FB) modalities for patients with liver metastases. Diagnostic computed tomographies (CT) of patients carrying one or two lesions &lt;4 cm and who underwent surgery were retrospectively screened and randomly selected for the study. For DIBH-SRS, a gross target volume (GTV) plus planning target volume (PTV) were delineated. For FB-SRS, a GTV plus an internal target volume (ITV) and PTV were defined. Accounting for the maximal GTV diameters, a modified GTV (GTV-IORT) was expanded circumferentially to simulate a resection cavity. The best suitable round-applicator size was thereafter selected. All treatment plans were calculated homogeneously to deliver 40 Gy. Doses delivered to organs at risk (OAR) and target volumes were compared for IORT vs. both SRS modalities. Eight patients encompassing 10 lesions were included in the study. The mean liver volume was 2,050.97 cm (SD, 650.82), and the mean GTV volume was 12.23 cm (SD, 12.62). As for target structures, GTV-IORT [19.44 cm (SD, 17.26)] were significantly smaller than both PTV DIBH-SRS [30.74 cm (SD, 24.64), p = 0.002] and PTV FB-SRS [75.82 cm (SD, 45.65), p = 0.002]. The median applicator size was 3 cm (1.5-4.5), and the mean IORT simulated delivery time was 45.45 min (SD, 19.88). All constraints were met in all modalities. Liver V showed significantly smaller volumes with IORT [63.39 cm (SD, 35.67)] when compared to DIBH-SRS [150.12 cm (SD, 81.43), p = 0.002] or FB-SRS [306.13 cm (SD, 128.75), p = 0.002]. No other statistical or dosimetrically relevant difference was observed for stomach, spinal cord, or biliary tract. Mean IORT D was 85.3% (SD, 6.05), whereas D for DIBH-SRS and FB-SRS were 99.03% (SD, 1.71; p = 0.042) and 98.04% (SD, 3.46; p = 0.036), respectively. Kilovoltage IORT bears the potential as novel add-on treatment for resectable liver metastases, significantly reducing healthy liver exposure to radiation in comparison to SRS. Prospective clinical evidence is required to confirm this hypothesis.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>34926271</pmid><doi>10.3389/fonc.2021.767468</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2234-943X
ispartof Frontiers in oncology, 2021-12, Vol.11, p.767468-767468
issn 2234-943X
2234-943X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_54b6e3c1a79d4658a6e712651bdd8860
source PubMed Central Free
subjects intraoperative
IORT
kilovoltage
liver metastases
Oncology
SRS
title Dosimetric Comparison of Intraoperative Radiotherapy and SRS for Liver Metastases
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T21%3A59%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dosimetric%20Comparison%20of%20Intraoperative%20Radiotherapy%20and%20SRS%20for%20Liver%20Metastases&rft.jtitle=Frontiers%20in%20oncology&rft.au=Scafa,%20Davide&rft.date=2021-12-02&rft.volume=11&rft.spage=767468&rft.epage=767468&rft.pages=767468-767468&rft.issn=2234-943X&rft.eissn=2234-943X&rft_id=info:doi/10.3389/fonc.2021.767468&rft_dat=%3Cproquest_doaj_%3E2612021730%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c415t-96dadd33dacceb2cb756863f2d0708f0f8a26eadc3df4c899315ece30203d1db3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2612021730&rft_id=info:pmid/34926271&rfr_iscdi=true